133 related articles for article (PubMed ID: 38299497)
1. Photoinduced Electron Transfer-Based Glutathione-Sensing Theranostic Nanoprodrug with Self-Tracking and Real-Time Drug Release Monitoring for Cancer Treatment.
Nisar S; Starosta E; Elayyan M; Regmi A; Sui B
ACS Appl Mater Interfaces; 2024 Feb; 16(6):6859-6867. PubMed ID: 38299497
[TBL] [Abstract][Full Text] [Related]
2. A Simple Glutathione-Responsive Turn-On Theranostic Nanoparticle for Dual-Modal Imaging and Chemo-Photothermal Combination Therapy.
Li Y; Wu Y; Chen J; Wan J; Xiao C; Guan J; Song X; Li S; Zhang M; Cui H; Li T; Yang X; Li Z; Yang X
Nano Lett; 2019 Aug; 19(8):5806-5817. PubMed ID: 31331172
[TBL] [Abstract][Full Text] [Related]
3. Redox Dual-Responsive and O
Chen H; Li F; Yao Y; Wang Z; Zhang Z; Tan N
Theranostics; 2019; 9(1):90-103. PubMed ID: 30662556
[TBL] [Abstract][Full Text] [Related]
4. A novel carbon-nanodots-based theranostic nano-drug delivery system for mitochondria-targeted imaging and glutathione-activated delivering camptothecin.
Gong X; Wang Z; Zhang L; Dong W; Wang R; Liu Y; Song S; Hu Q; Du F; Shuang S; Dong C
Colloids Surf B Biointerfaces; 2022 Oct; 218():112712. PubMed ID: 35921692
[TBL] [Abstract][Full Text] [Related]
5. A Glutathione (GSH)-Responsive Near-Infrared (NIR) Theranostic Prodrug for Cancer Therapy and Imaging.
Kong F; Liang Z; Luan D; Liu X; Xu K; Tang B
Anal Chem; 2016 Jun; 88(12):6450-6. PubMed ID: 27216623
[TBL] [Abstract][Full Text] [Related]
6. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Wang Z; Wu H; Liu P; Zeng F; Wu S
Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
[TBL] [Abstract][Full Text] [Related]
7. Stimuli-Responsive Nanotheranostics for Real-Time Monitoring Drug Release by Photoacoustic Imaging.
Yang Z; Song J; Tang W; Fan W; Dai Y; Shen Z; Lin L; Cheng S; Liu Y; Niu G; Rong P; Wang W; Chen X
Theranostics; 2019; 9(2):526-536. PubMed ID: 30809290
[TBL] [Abstract][Full Text] [Related]
8.
Dong Y; Du P; Liu P
Int J Pharm; 2020 Oct; 588():119723. PubMed ID: 32755688
[TBL] [Abstract][Full Text] [Related]
9. Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor.
Yang X; Shi X; Ji J; Zhai G
Drug Deliv; 2018 Nov; 25(1):780-796. PubMed ID: 29542333
[TBL] [Abstract][Full Text] [Related]
10. Stimuli-responsive theranostic system: A promising approach for augmented multimodal imaging and efficient drug release.
Demiral A; Goralı Sİ; Yılmaz H; Verimli N; Çulha M; Erdem SS
Eur J Pharm Biopharm; 2022 Aug; 177():9-23. PubMed ID: 35671914
[TBL] [Abstract][Full Text] [Related]
11. Noncovalent Theranostic Prodrug for Hypoxia-Activated Drug Delivery and Real-Time Tracking.
Zhao XB; Gao K; Shi YP
Anal Chem; 2021 Nov; 93(45):15080-15087. PubMed ID: 34743509
[TBL] [Abstract][Full Text] [Related]
12. Folate-receptor-targeted laser-activable poly(lactide-
Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
[TBL] [Abstract][Full Text] [Related]
13. Disulfide-based multifunctional conjugates for targeted theranostic drug delivery.
Lee MH; Sessler JL; Kim JS
Acc Chem Res; 2015 Nov; 48(11):2935-46. PubMed ID: 26513450
[TBL] [Abstract][Full Text] [Related]
14. Theranostic Upconversion Nanobeacons for Tumor mRNA Ratiometric Fluorescence Detection and Imaging-Monitored Drug Delivery.
Ding Q; Zhan Q; Zhou X; Zhang T; Xing D
Small; 2016 Nov; 12(43):5944-5953. PubMed ID: 27647762
[TBL] [Abstract][Full Text] [Related]
15. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
18. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
19. Framework Nucleic Acid-Based Multifunctional Tumor Theranostic Nanosystem for miRNA Fluorescence Imaging and Chemo/Gene Therapy.
Luo H; Wang Z; Mo Q; Yang J; Yang F; Tang Y; Liu J; Li X
ACS Appl Mater Interfaces; 2023 Jul; 15(28):33223-33238. PubMed ID: 37421332
[TBL] [Abstract][Full Text] [Related]
20. Self-Monitoring and Self-Delivery of Photosensitizer-Doped Nanoparticles for Highly Effective Combination Cancer Therapy in Vitro and in Vivo.
Zhang J; Liang YC; Lin X; Zhu X; Yan L; Li S; Yang X; Zhu G; Rogach AL; Yu PK; Shi P; Tu LC; Chang CC; Zhang X; Chen X; Zhang W; Lee CS
ACS Nano; 2015 Oct; 9(10):9741-56. PubMed ID: 26390118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
